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Abstract
Background:  The hepatic stellate cell is the primary cell type responsible for the excessive
formation and deposition of connective tissue elements during the development of hepatic fibrosis
in chronically injured liver. Culturing quiescent hepatic stellate cells on plastic causes spontaneous
activation leading to a myofibroblastic phenotype similar to that seen in vivo. This provides a simple
model system for studying activation and transdifferentiation of these cells. The introduction of
exogenous DNA into these cells is discussed controversially mainly due to the lack of systematic
analysis. Therefore, we examined comparatively five nonviral, lipid-mediated gene transfer methods
and adenoviral based infection, as potential tools for efficient delivery of DNA to rat hepatic stellate
cells and their transdifferentiated counterpart, i.e. myofibroblasts. Transfection conditions were
determined  using  enhanced  green  fluorescent  protein  as  a  reporter  expressed  under  the
transcriptional control of the human cytomegalovirus immediate early gene 1 promoter/enhancer.
Results:  With the use of chemically enhanced transfection methods, the highest relative efficiency
w a s  o b t a i n e d  w i t h  F u G E N E ™ 6  g e n e  m e d i a t e d  D N A  t r a n s f e r .  Q u a n t i t a t i v e  e v a l u a t i o n  o f
representative transfection experiments by flow cytometry revealed that approximately 6% of the
rat hepatic stellate cells were transfected. None of the transfection methods tested was able to
mediate  gene  delivery  to  rat  myofibroblasts.  To  analyze  if  rat  hepatic  stellate  cells  and
myofibroblasts are susceptible to adenoviral infection, we have inserted the transgenic expression
cassette into a recombinant adenoviral type 5 genome as replacement for the E1 region. Viral
particles of this replication-deficient Ad5-based reporter are able to infect 100% of rat hepatic
stellate cells and myofibroblasts, respectively.
Conclusions:  Our results indicate that FuGENE™6-based methods may be optimized sufficiently
to offer a feasible approach for gene transfer into rat hepatic stellate cells. The data further
demonstrate that adenoviral mediated transfer is a promising approach for gene delivery to these
hepatic cells.
Background
Transfection is the insertion of foreign molecules such as
cDNAs or promoter constructs into eukaryotic cells. This
method has become a powerful experimental tool for
studying gene functions and to analyze the control of
gene expression. Genes of interest can either be trans-
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fected transiently or stable into cultured mammalian
cells. Detailed protocols for efficient gene transfer to var-
ious primary cells and continuous cell lines, irrespective
whether these cells are grown as monolayers or in sus-
pension have been established during the last decades.
Many methods have been developed to overcome the low
transfection efficiency in differentiated cells if classical
approaches, such as calcium-phosphate-DNA coprecipi-
tates [1], diethylaminoethyl (DEAE)-dextran [2] or poly-
lysine mediated gene transfer [3] are applied.
Transfection by electroporation, microinjection, biolistic
particle delivery, activated dendrimers or cationic lipo-
somes are useful for established cell lines [4,5,6,7,8].
However, in cells of primary culture most of these trans-
fection systems proved to be inefficient. Direct introduc-
tion of genes into rat hepatic stellate cells (rHSCs) and
their transdifferentiated phenotype, i.e. the rat myofi-
broblasts (rMFBs) is difficult to achieve, in part due to
the quiescent and fragile phenotype of rHSCs or the ex-
tracellular matrix in which the rMFBs are embedded. In
normal liver, quiescent HSCs (also called Ito cells,
lipocytes, fat-storing cells) are the precursor cells for
MFBs, which are responsible for the dramatic increase in
the synthesis of extracellular matrix proteins in cirrhotic
livers [9,10]. Upon fibrogenic stimuli, HSCs become ac-
tivated, a process in which they loose vitamin A granules,
proliferate, change morphologically into MFBs, and in-
crease their synthesis of extracellular matrix proteins [11,
12]. Culture of quiescent HSCs on a plastic surface also
results in spontaneous activation of these cells similar to
that seen in liver fibrosis in vivo. Efficient gene delivery
to cultured rHSCs and rMFBs would therefore be of great
interest for studying the processes involved in hepatic fi-
brogenesis and for gene-therapeutic devices. To compare
various transfection mediators for their potential to in-
crease the efficiency of gene delivery to rHSC and rMFB
we used the reporter plasmid pEGFP-C1 expressing the
enhanced green fluorescent protein (EGFP) from the jel-
lyfish Aequorea victoria as a reporter expressed under
transcriptional control of the ubiquitously active human
cytomegalovirus (CMV) immediate early gene 1 promot-
er. Transfections were performed with the commercially
available cationic liposome reagents Effectene, Lipo-
fectAmine Plus, Superfect, a classical calcium phosphate
based method with and without glycerol shock, and the
lipid-based reagent FuGENE™6, respectively. Further-
more, we cloned an adenovirus type 5 reporter construct
(Ad5-CMV-EGFP) harboring the CMV/EGFP transgene
and showed that high levels of gene transfer can be
achieved in rHSC/rMFB with recombinant replication-
deficient viral particles generated thereof. Taken togeth-
er, we conclude that (i) gene delivery to rHSC can be per-
formed by transfection with FuGENE™6 as mediator
and that (ii) Ad5-mediated gene delivery can serve as a
useful tool for introduction foreign DNA into cultured
rHSC/rMFB, particularly if high gene delivery rates are
required.
Results and discussion
To analyze the benefits and disadvantages of various
transfection vehicles the efficiency of gene delivery to
rHSC and rMFB was determined using the reporter plas-
mid pEGFP-C1 expressing the enhanced green fluores-
cent protein (EGFP) under transcriptional control of the
human cytomegalovirus (CMV) promoter. We compared
the cationic liposome reagents Effectene, LipofectAmine
Plus, Superfect, a classical calciumphosphate based
method with and without glycerol shock, and the lipid-
based reagent FuGENE™6 applying essentially the pro-
tocols given by the manufacturers. As control for evalua-
tion of the suitability of each transfection protocol we
transfected NIH/3T3 cells in parallel under the same
conditions. This continuous cell line of murine embryon-
ic fibroblastic origin has been reported previously to be
highly transfectable with all reagents used in this study.
Forty-eight hours after transfection we analyzed the
morphology and viability of cells. Phase contrast micros-
copy revealed that rHSCs/rMFBs remained viable and
continued to grow normally. To estimate the rate of
transfection we counted EGFP positive and negative cells
in the fluorescence microscopy. Although transfection
efficiencies for the established cell line NIH/3T3 was in
the expected range (Effectene ~9.5%, LipofectAmine
Plus ~7.5%, Superfect ~2.5%, calcium-phosphate/ -glyc-
erol shock ~8%, calcium-phosphate/+glycerol shock
~12%, FuGENE™6 ~30%) there was obviously an over-
all low transfection rate of rHSCs and rMFBs.
Interestingly, only FuGENE™6 was able to mediate a
significant gene transfer (~ 6%) to rHSCs (Fig. 1). None
of the mediators tested was able to provide sufficient
gene delivery in rMFBs. FACS analysis was used to esti-
mate the percentage of transfected cells. EGFP has a sin-
gle red-shifted excitation peak at 488 nm which is
suitable for flow cytometric analysis by argon ion laser
excitation and a standard FITC filter set [13]. The viabil-
ity of transfected cells was proven by double staining
with propidium iodide (PI), which selectively stains dead
cells. Fluorescence signals were acquired using a 488 nm
excitation and a 530 ±  30 nm emission fluorescence filter
for EGFP and a 630 ±  11 nm emission fluorescence filter
for PI, respectively. This "double staining" protocol al-
lows to discriminate between viable but not transfected
cells, non viable and not transfected cells, viable trans-
fected cells and dead transfected cells. Representative re-
sults obtained after transfection with FuGENE™6 as
vehicle are summarized in Fig. 2. In agreement with our
microscopic results (see above) 6% of rHSC were found
to be positive for EGFP. The transfected cells are viable
as evidenced by the lack of PI staining. Furthermore, theBMC Cell Biology (2000) 1:4 http://www.biomedcentral.com/1471-2121/1/4
flow cytometric analysis revealed that the non viable
rHSC were negative for EGFP. The fraction of about 11%
dead rHSC may be due to destructive effects of trypsini-
zation and washing procedures on these fragile cells.
rMFB were transfectable neither with FuGENE™6 nor
with the other non viral transfection systems tested. The
fraction of 30% transfected NIH/3T3 cells documents
the correct handling of the transfection protocol.
It was previously shown that the lipid formulation Fu-
GENE™6 is able to promote DNA uptake by primary thy-
rocytes and articular chondrocytes known to be
refractory to most transfection systems [14, 15]. In our
hands none of the five transfection systems tested was
able to (>0.5%) provide significant gene delivery to rMF-
Bs. Human MFBs isolated from outgrowths of cirrhotic
Figure 1
Representative analysis of transfection efficiencies of
rat  hepatic  stellate  cells  and  myofibroblasts  using
FuGENE™6 transfection procedure. Rat hepatic  s te l-
late cells (rHSCs) were isolated from adult male Sprague-
Dawley rats by the pronase-collagenase method and a single-
step  density  gradient  centrifugation.  Rat  myofibroblasts
(rMFBs) were prepared by subculturing primary rHSCs by
trypsinization at day 7 after seeding following spontaneous
activation on a plastic surface. The established murine cell
line NIH/3T3 served as a reporter transfection cell line. Cells
were transfected with 2 µ g of reporter construct pEGFP-C1
and  FuGENE™6  according  to  the  suppliers  instructions.
After incubation for proposed time media were changed and
transfection  efficiencies  were  monitored  48  hours  after
transfection. Representative phase contrast microscopy (A,
C, E) and fluorescence microscopy (B, D, F) of rHSCs (A,
B), rMFBs (C, D) and NIH/3T3 cells (E, F) are shown. The
intensity of fluorescence varies among transfected cells indi-
cating various levels of reporter expression.
Figure 2
Representative results of flow cytometric analysis of
transfected rat hepatic stellate cells and rat myofi-
broblasts  in  comparison  to  NIH/3T3  cells  using
FuGENE™6 vehicle. For this experiment rHSCs, rMFBs
and NIH/3T3 cells were transfected 2 days after seeding with
2  µ g  reporter  plasmid  complexed  with  5  µ l  FuGENE™6.
FACS  analysis  was performed 48 hours after transfection.
Cultured cells  were trypsinized under standard conditions
and flow cytometric measurements were performed immedi-
ately  after  collection  of  cells.  Fluorescence  signals  were
recorded with a flow cytometer FACS-Calibur (Becton Dick-
inson, Sparks, MD) using a 488 nm excitation and a 530 ±  30
nm emission fluorescence filter for enhanced green fluores-
cence protein (EGFP) and a 630 ±  11 nm emission fluores-
cence filter for propidium iodide (PI), respectively. Data were
acquired and analyzed with the CellQuest™ software ver-
s i o n  3 . 1  ( B e c t o n  D i c k i n s o n ) .  H i s t o g r a m s  o f  f l u o r e s c e n c e
intensities in EGFP (A, C, E) and PI (B, D, F) channels are
shown for rHSC (A, B), rMFB (C, D) and reporter cell line
NIH/3T3 (E, F), respectively. To establish background for
fluorescence  and  to  set  gates  for  data  acquisition,  mock-
transfected cells (not shown) were used. Mean fluorescence
intensity was used to calculate levels of EGFP expression.
Cells that  took  up  PI  were  deemed nonviable.  Nontrans-
fected cells did not show fluorescence in EGFP channel.BMC Cell Biology (2000) 1:4 http://www.biomedcentral.com/1471-2121/1/4
liver pieces and cells from the established line CFSC [16]
derived from cirrhotic rHSCs were highly transfectable
with all mediators (not shown). A potential reason for
the observed higher transfection susceptibility of human
MFBs and immortalized rMFBs might be the difference
in the rate of cell proliferation. A connection between ef-
fective gene transfer and mitotic activity was recently
demonstrated in various cells and is also well document-
ed in smooth muscle cells [17, 18].
To test if adenoviral gene delivery is a suitable alternative
to overcome the observed insufficient gene delivery rates
we analyzed the susceptibility of rHSCs and rMFBs to ad-
enoviruses. To facilitate the insertion of the CMV/EGFP
reporter cassette within an appropriate adenoviral shut-
tle vector we cut pEGFP-C1 with AsnI and SspI, filled in
the resulting 1.66-kbp fragment with Klenow DNA
polymerase and inserted this fragment into the filled in
EcoRI site of vector p∆ E1sp1A (Fig. 3A) [19]. The orien-
tation of the reporter transgene and the cloning bounda-
ries in the resulting vector p∆ E1sp1A-CMV-EGFP were
confirmed by digestion with multiple restriction endonu-
cleases and sequencing. We then cotransfected vector
p∆ E1sp1A-CMV-EGFP and backbone vector pJM17 [20]
into the packaging cell line 293 [21], which supplies the
missing adenoviral E1 gene products necessary to gener-
ate recombinant viral particles (Fig. 3B and 3C). Based
on reports describing that the integrated colinear Ad5-
segment spanning bp 1 to bp 4344 of Ad5 genome [22] is
transcriptionally silenced or lost frequently in 293 cul-
tures at high passage numbers we first tested whether
corresponding Ad5-genes (E1A and E1B) were actively
transcribed in the 293 cells used in this study. Therefore,
we performed a Northern blot analysis (Fig. 4) with total
RNA of 293 cells and the 2.8-kbp EcoRI/HindIII frag-
ment of vector pAd5SalIB containing bp 1 to bp 2804 of
Ad5 genome (cf. GenBank Accession number X02996.1)
[23]. The sizes of observed hybridization signals (1.3 kb
and 2.6 kb) expressed at high levels are in agreement
with the complexity of the primary transcripts for E1A
(1134 nt) and E1B (2369 nt) genes if in addition 200 nt
for poly A+-tail are estimated. In the murine control cell
line NIH/3T3 transcripts of E1A or E1B are virtually ab-
sent due to the absence of Ad5 sequences in these cells.
The Northern analysis therefore revealed that the 293
cells used in this study are able to produce relevant mR-
NAs for both trans-activator genes. Twenty four hours
after cotransfection of p∆ E1sp1A-CMV-EGFP and pJM17
approximately 40% of 293 cells were positive for EGFP
(not shown). Six days later the typical viral focies which
are able to produce recombinant viral particles were ob-
served and 7-12 days after transfection all cells were in-
fected by developing recombinant Ad5-CMV-EGFP
particles. Viral particles were isolated, amplified once on
293 cells and purified by standard procedures.
To test the susceptibility of cultured rHSC/rMFB we in-
fected them two days after seeding using a multiplicity of
infection (MOI) of 10. Analysis of the cells for forty-eight
hours after infection revealed that 100% of the cells (rH-
SCs and rMFBs) were positive for EGFP providing evi-
dence that adenoviral based vectors are very effective in
gene delivery to these cells in culture (Fig. 5). However,
it was surprising that the use of adenovirus at a MOI of
10 was sufficient for complete infection. It is well estab-
lished that the internalization of adenoviral particles is
promoted by integrins [24]. Also, it was previously dem-
onstrated that HSC and MFB express high levels of vari-
ous types of integrins [25, 26]. Therefore, it is most likely
that the observed high adenoviral susceptibility of HSC
and MFB may be caused by high-level expression of in-
tegrins. Interestingly, also the relative intensities of fluo-
rescence signals in these cells were extremely high
compared to those observed after chemically enhanced
gene delivery (compare Fig. 5B and Fig. 1B). Infected
cells continued to express the product of the transgene
(EGFP) for at least 2 weeks. It is most likely that the ter-
mination of transgene expression after 2 weeks is related
to the loss of episomal transgene, which is not incorpo-
rated into the host genome and, therefore, is lost with cell
division. Partial cellular disintegration occurred (not
shown) at later stages most likely due to the intrinsic cy-
totoxicity of high EGFP content or the overexpression of
some viral proteins [27]. Independent experiments re-
vealed further that infection of these sinusoidal hepatic
cells is highly reproducible, irrespective whether infec-
tion is performed in the presence of 2%, 5% or 10% fetal
calf serum (not shown).
Based on these data we conclude that a MOI of 10 is suf-
ficient to achieve an infection of 100% in cultured rHSC
and rMFB, respectively, under most experimental condi-
tions.
Conclusions
In agreement with other reports on gene delivery to cul-
tured rHSCs by adenoviral based techniques our data
show that this method is straightforward particularly
when high efficiency of gene transfer is required
[28,29,30,31]. Furthermore, our report indicates that in-
troduction of foreign DNA even into rMFBs is possible by
use of adenoviral based vector systems. Because of the
considerable interest on the rHSC/rMFB transition as a
cell culture model for liver fibrogenesis the improvement
of efficiency of gene delivery to these cells should facili-
tate applications such as reproducible reporter vector as-
says, or bulk expression of signalling proteins for
biochemical or cell biological assays.BMC Cell Biology (2000) 1:4 http://www.biomedcentral.com/1471-2121/1/4
Figure 3
Construction of a replication-defective recombinant adenovirus expressing enhanced green fluorescent pro-
tein under transcriptional control of the human cytomegalovirus immediate-early gene 1 promoter/enhancer.
(A) In the mammalian reporter vector pEGFP-C1 the enhanced green fluorescent protein (EGFP) is expressed under control
of the human cytomegalovirus immediate-early gene 1 promoter (PCMV). Abbreviations are: Kan/Neo, kanamycin/neomycin
resistance genes; Amp, ampicillin resistance gene; pUC ori, E. coli origin of replication; SV40 ori, simian virus 40 origin of repli-
cation; SV40 polyA, simian virus 40 polyadenylation signal; HSVTK polyA, herpes simplex thymidine kinase polyadenylation sig-
nal. The adenoviral shuttle vector p∆ E1sp1A contains Ad5 sequences from bp 22 (0 mu) to bp 5790 (16.1 mu) with a deletion
of E1 sequences (∆ E1) from bp 342 to bp 3523 (1.0 - 9.8 mu) and a selectable ampicillin resistance gene (Amp). A multiple clon-
ing site (MCS) containing unique restriction sites for ClaI, BamHI, XhoI, XbaI, EcoRV, EcoRI, HindIII, SalI, and BglII is embedded in
the  Ad5-sequences.  For construction  shuttle  vector  p∆ E1sp1A-CMV-EGFP  the  1656-bp AsnI/SspI  fragment from  plasmid
pEGFP-C1 was filled in by Klenow DNA polymerase and cloned into the EcoRI digested and filled in p∆ E1sp1A vector.(B) For
integration of the reporter cassette from pE1∆ sp1A-CMV-EGFP into the Ad5 backbone plasmid vector pJM17 both plasmids
were cotransfected into human embryo kidney cell line 293 leading to homologous recombination between common Ad5
regions. Generation of recombinant viral particles were visualized by an increase of EGFP-positive cells and by viral focus for-
mation in fluorescence microscopy. (C) Released replication-defective viral particles are infectious and are capable to deliver
the CMV-EGFP cassette to target cells. The nucleotide sequence of the cloned vector p∆ E1sp1A-CMV-EGFP is deposited in
GenBank (Accession number AF288620).BMC Cell Biology (2000) 1:4 http://www.biomedcentral.com/1471-2121/1/4
Additional studies will be required to determine the op-
timal in vivo conditions for adenoviral gene transfer to
rHSCs/rMFBs.
Material and Methods
Isolation and culture of rat hepatic stellate cells
All animal protocols were in full compliance with the
guidelines for animal care and were approved by the An-
imal Care Committee from the government. Adult male
Sprague-Dawley rats (Harlan Winkelmann GmbH,
Borchen, Germany), which had free access to altromin
chow (Altromin GmbH, Lage, Germany) and water were
anaesthetized with an intramuscular injection of 100
mg/kg body weight ketaminhydrochloride (Ketavet®;
SANOFI-CEVA GmbH, Düsseldorf, Germany) and 7 mg/
kg body weight xylazinhydrochloride (Rompun®; Bayer-
Vital, Leverkusen, Germany). rHSCs were isolated by the
pronase-collagenase method, a two-step method for
preparation of rat liver cells comprising a first step in
which the liver is pre-perfused with a Ca2+-free medium
in order to remove intercellular Ca2+, and a second step
in which the liver is perfused with a Ca2+ requiring colla-
genase mixture [32, 33, 34]. Briefly, livers were perfused
at 10 ml/minute with 200 ml Hanks balanced salt solu-
tion (HBSS) without Ca2+and Mg2+ (PAA Laboratories
GmbH, Linz, Austria), 100 ml solution E [0.35% (w/v)
pronase E in HBSS with Ca2+ and Mg2+] followed by re-
circulating perfusion for approximately 30 minutes with
60 ml solution F [0.015% (w/v) collagenase in HBSS
with Ca2+ and Mg2+]. Thereafter, livers were dissected
under permanent pH control (pH 7.3) in 100 ml HBSS
with Ca2+ and Mg2+ containing 10 mg DNase, type II
(Roche, Mannheim, Germany). The cell suspension was
subsequently filtered through nylon mesh (250 µ m and
100 µ m) and centrifuged for 7 minutes at 450 ×  g at 4° C.
The resulting pellet was washed in ice cold solution G
containing 0.25% (w/v) bovine serum albumin in HBSS/
+Ca2+/+Mg2+. rHSCs were purified by single-step densi-
ty gradient centrifugation with 8.25% (w/v) Nycodenz®
(Nycomed Pharma AS, Oslo, Norway) as described in de-
tail elsewhere [33]. rHSCs were carefully collected by as-
piration of the white top layer of the gradient. The purity
of cell preparations was assessed by light microscopic
appearance, vitamin A autofluorescence of the cells and
positive immunofluorescence stainings [35]. rMFBs
were prepared by subculturing primary rHSCs by
trypsinization at day 7 after seeding following spontane-
ous activation on the plastic surface. rHSCs and rMFBs
were cultured in Dulbecco's modified Eagle medium
(DMEM; BioWhittaker Europe, Verviers, Belgium) con-
taining 4 mM L-glutamine and 10% fetal calf serum (Se-
romed, Biochrom KG, Berlin, Germany). Additionally,
Figure 4
Expression of E1A and E1B transactivators in human
embryo kidney cell line 293. A Northern blot analysis
using  equal  amounts  (30  µ g )  o f  t o t a l  c e l l u l a r  R N A  f r o m
human embryo kidney 293 cells (HEK293) and NIH/3T3 cells
is shown. The blotted RNAs were hybridized with 3.5 ×  107
cpm of a [α -32P]dCTP-labelled 2.8-kbp EcoRI/HindIII fragment
of clone pAd5SalIB23 containing complete E1A-gene and par-
tial E1B-gene of Ad5. The autoradiograph was exposed for 3
hours using an intensifying screen. The RNAs were rehybrid-
ized with 1.5 ×  107 cpm of a [α -32P]dCTP-labelled GAPDH-
specific cDNA probe, and filter was re-exposed for 3 hours.
Figure 5
Adenoviral infection of rHSCs and rMFBs with Ad5-
CMV-EGFP. For infection of rHSCs/rMFBs with Ad5-CMV-
EGFP 105 cells were seeded in 2 ml medium and infected 2
days later with 500 µ l viral stock containing approximately
106  plaque  forming  units.  Representative  phase-contrast
microscopy (A, C) and fluorescence microscopy (B, D) of
rHSC (A, B) and rMFB (C, D) 48 hours after adenoviral
infection are shown. Mock infected rHSCs or rMFBs are neg-
ative for EGFP-expression (not shown).BMC Cell Biology (2000) 1:4 http://www.biomedcentral.com/1471-2121/1/4
all culture media were supplemented with penicillin (100
IU/ml) and streptomycin (100 µ g/ml), respectively. All
cultures were maintained at 37° C and 5% CO2 in a hu-
midified atmosphere.
The murine fibroblast cell line NIH/3T3 [36] was pur-
chased from the American Type Culture Collection
(Rockville, MD) and maintained in culture at 37° C in
DMEM supplemented with 10% fetal calf serum, 4 mM
L-glutamine, penicillin (100 IU/ml) and streptomycin
(100 µ g/ml). All transfections of NIH/3T3 cells with var-
ious transfection agents were performed at approximate-
ly 60% confluency.
Transfection of hepatic stellate cells
The reporter construct pEGFP-C1 (GenBank Accession
number U55763) was purchased from CLONTECH (Palo
Alto, CA). rHSCs were transfected two days after seed-
ing, rMFBs cells two days after subculturing (see above)
with 2 µ g plasmid DNA. The DNA was isolated by a
standard alkaline extraction method or a cesium chloride
gradient purification protocol. Transfections were per-
formed with the commercially available cationic lipo-
some reagents Effectene (Qiagen, Hilden, Germany),
LipofectAmine Plus (Gibco Life Technologies, Karlsruhe,
Germany), Superfect (Qiagen), the lipid-based reagent
FUGENE™6 (Roche), and a classical calciumphosphate
based method (Promega, Madison, WI) with and without
glycerol shock, following essentially the instructions of
the manufacturers. For glycerol shock the medium was
removed, cells were rinsed in HBSS/-Ca2+/-Mg2+ three
times and overlayed with 15% glyerol in HBSS/-Ca2+/-
Mg2+for 2 minutes at 37° C. Thereafter, glycerol solution
was removed and cells were washed three times with
HBSS/-Ca2+/-Mg2+prior addition of regular growth me-
dium. Transfection efficiencies were monitored 48 hours
later by fluorescence microscopy and flow cytometry
analysis.
Microscopic data documentation
Microscopic images shown are from representative ex-
periments. For visual observation of transfected and in-
fected cells expressing EGFP, we typically used a 40 ×
objective lens and a 10 ×  eyepiece lens. Documentation of
representative eye fields had been performed with a HV-
C20 digital camera (HITACHI Denshi Ltd., Tokyo, Ja-
pan) and the DISKUS software package version 4.14
(Hilgers, Königswinter, Germany).
Flow Cytometry
Flow cytometric measurements were performed imme-
diately after collection of cultured cells. Cells were
trypsinized under standard conditions and washed once
with HBSS/-Ca2+/-Mg2+. To get informations about via-
bility, collected cells were additionally stained with pro-
pidium iodide (PI) (Sigma, Deisenhofen, Germany).
Fluorescence signals were recorded with a flow cytome-
ter FACS-Calibur (Becton Dickinson, Sparks, MD) using
a 488 nm excitation and a 530 ±  30 nm emission fluores-
cence filter for EGFP and a 630 ±  11 nm emission fluores-
cence filter for PI, respectively. Data were acquired and
analyzed with the CellQuest™ software version 3.1 (Bec-
ton Dickinson).
Construction of replication-defective recombinant adeno-
viruses
Plasmids p∆ E1sp1A [19] and pJM17 [20] for construc-
tion of adenoviral vector were obtained from Microbix
Biosystems Inc. (Toronto, Ontario, Canada). For con-
struction the adenoviral reporter shuttle vector
p∆ E1sp1A-CMV-EGFP the 1656-bp AsnI/SspI fragment
from plasmid pEGFP-C1 was filled in by Klenow DNA
polymerase and cloned into the EcoRI digested and Kle-
now filled in p∆ E1sp1A. The orientation of the CMV-
EGFP expression cassette in p∆ E1sp1A-CMV-EGFP and
the integrity of cloning boundaries were verified by re-
striction analysis and sequencing with flanking primers
5'-d(GCGTAACCGAGTAAGAATTTG)-3' and 5'-
d(GGCGACCATCAATGCTGGAG)-3', respectively. Prim-
ers were obtained from MWG- Biotech AG (Ebersberg,
Germany) and sequence reactions were done with the
ABI PRISM BigDye® termination reaction kit (PE Ap-
plied Biosystems, Weiterstadt, Germany). Integration of
vector sequences from p∆ E1sp1A-CMV-EGFP into aden-
oviral backbone vector pJM17 for production of replica-
tion-deficient virus particles were performed by in vitro
homologous recombination in the human embryo kidney
cell line 293, which constitutively express the E1 gene
products required for propagation of recombinant aden-
oviruses [21]. Briefly, approximately 5 ×  105 293 cells
were seeded in six-well dishes and cotransfected with 2
µ g of plasmid p∆ E1sp1A-CMV-EGFP, 2 µ g pJM17 and 10
µ l of the FuGENE™6 reagent. After 16 hours at 37° C, the
media containing the transfection mix was removed, and
2 ml of growth medium was added and cells were cul-
tured for 10-12 days with subsequent addition of fresh
medium. Generation of recombinant viral particles were
visualized by increase of EGFP-positive cells and by viral
foci formation in fluorescence microscopy. After total in-
fection viral particles were released from cells by three
rounds of a freeze-thaw cycle. Viral particles were sepa-
rated from cell debris by centrifugation at 3000 rpm for
10 minutes. To generate higher titer viral stocks, 293
cells were re-infected at a multiplicity of infection (MOI)
of 1 and grown for 3-4 days, at which time viruses were
harvested as described above.
Adenoviral infection
Viral stock solutions were titered on 293 cells in growth
medium containing 10% fetal calf serum following stand-BMC Cell Biology (2000) 1:4 http://www.biomedcentral.com/1471-2121/1/4
ard procedures [37] and kept frozen at -20° C until use.
For infection of rHSCs/rMFBs with adenoviral particles
105 cells were seeded in six-well dishes with 2 ml medi-
um and cells were infected 2 days later with 500 µ l viral
stock containing approximately 10 6 plaque forming
units of Ad5-CMV-EGFP.
RNA isolation and Northern analysis
Cells from human cell line 293 and murine cell line NIH/
3T3 were rinsed with ice cold HBSS/-Ca2+/-Mg2+, and
then lysed in 1 ml per 106 cells of lysis buffer containing
25 mM sodium acetate pH 6.0, 4 M guanidine thiocy-
anate and 0.835% (v/v) β -mercaptoethanol. The lysate
was adjusted to 8 ml with lysis buffer, pressed three
times through a 20-g needle, layered onto a 4-ml cushion
of a solution containing 25 mM sodium acetate pH 6.0
and 5.7 M cesium chloride, and then centrifuged for ap-
proximately 24 h at 21° C and 25000 rpm in a Beckman
SW41-type rotor. RNA pellets were resuspended in 300
mM sodium acetate (pH 6.0), ethanol precipitated and
resuspended in water. The concentration of RNA was de-
termined by absorbance at 260 nm.
For Northern analysis, 30 µ g of total cellular RNAs were
separated by electrophoresis in a 1.2% (w/v) denaturing
agarose gel, transferred to a Hybond-N membrane (Am-
ersham Pharmacia Biotech, Freiburg, Germany) and
fixed by baking for 2 h at 80° C. Blots were pre-hybridized
for at least 3 h, and then hybridized for 16 h at 37° C to [α -
32P]dCTP-labelled probes (Multiprime DNA labelling
system; Amersham) in a buffer containing 50% (v/v) for-
mamide, 6 ×  SSC, 5 ×  Denhardt's solution [0.1% (w/v) Fi-
coll 400, 0.1% (w/v) BSA, 0.1% polyvinylpyrrolidone], 5
mM EDTA, 0.5% (w/v) SDS, and 100 µ g/ml sheared de-
natured herring sperm DNA (Roche). Filters were
washed once at 55° C for 20 minutes in a solution con-
taining 2 ×  SSC, 1 mM EDTA, and 0.1% (w/v) SDS, then
twice at 50° C for 20 minutes in a solution containing 0.4
×  SSC, 1 mM EDTA, and 0.1% (w/v) SDS. Autoradio-
graphs were exposed for indicated times to Kodak X-
OMAT AR films at -80° C using intensifying screens. As
an internal standard (loading control) the blots were re-
hybridized with a GAPDH specific cDNA.
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